United Kingdom
Search    
Include All CSL Behring Country Sites

For Healthcare Professionals
CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products including:
null Coagulation therapies
For rapid warfarin reversal, von Willebrand disease, haemophilia and congenital fibrinogen deficiency
null Immunology therapies
For hereditary angioedema, immune deficiency disorders, and haemolytic disease of the newborn
Resource centre for healthcare professionals